Juror Analyticals & Research Private Limited
About Juror Analyticals & Research Private Limited
Data last updated:
Juror Analyticals & Research Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 17 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74999MP2016PTC040769.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹10 Lakh. It is led by director Naman Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 142 Shanti Niketan Near Bombay Hospital, Indore, Madhya Pradesh, India – 452010.
As per the financials filed for FY 2025, the company reported a revenue of ₹50,030, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹5,080 (net margin 10.2%) and EBITDA of ₹6,610 (EBITDA margin 13.2%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Juror Analyticals & Research Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address142 Shanti Niketan Near Bombay Hospital, Indore, Madhya Pradesh, India – 452010
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Juror Analyticals & Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Juror Analyticals & Research Private Limited
FY 2025 filings availableJuror Analyticals & Research Private Limited reported revenue of ₹50,030 (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 30% over three years, including 5% growth in the latest year. EBITDA rose 993% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6,610 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5,080 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.2% | ||||
| Net Profit Margin | 10.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Juror Analyticals & Research Private Limited, buy the company report.
Board of directors of Juror Analyticals & Research Private Limited
Juror Analyticals & Research has 1 current director and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naman Sharma | Director | 17 May 2016 | 10 Years 5 Months | Current |
Peer comparison
Juror Analyticals & Research Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Malamed Life Science Private Limited | ₹72,000 (FY 2024) | Chennai, Tamil Nadu, India | ||||
| Ray Futuro Private Limited (OPC) | ₹70,200 (FY 2022) | Mumbai, Maharashtra, India | ||||
| Sphaera Pharma Research and Development Private Limited | ₹67,500 (FY 2025) | -83.0% | New Delhi, Delhi, India | |||
| Gomi'da Private Limited | ₹63,000 (FY 2024) | -96.0% | Noida, Uttar Pradesh, India | |||
| Ishaan Research Labortories Private Limited | ₹54,290 (FY 2024) | 0.0% | New Delhi, Delhi, India | |||
| Juror Analyticals & Research Private Limitedthis company | ₹50,030 (FY 2025) | ₹5,080 | 10.2% | 5.0% | Indore, Madhya Pradesh, India | |
| Stack Esolutions Private Limited | ₹48,580 (FY 2025) | -48.0% | New Delhi, Delhi, India | |||
| Envigo Research Private Limited | ₹47,000 (FY 2022) | 571.0% | Ahmedabad, Gujarat, India | |||
| Oshni Medicines Research and Development Organization Private Limited | ₹43,500 (FY 2025) | -89.0% | Namakkal, Tamil Nadu, India | |||
| Novita Healthntech Private Limited | ₹40,389 (FY 2023) | 8.0% | Hyderabad, Telangana, India | |||
| Institute of Pharmaceutical & Healthcare Management and Rese | ₹39,624 (FY 2025) | 3.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Juror Analyticals & Research Private Limited, buy the company report.
Auditor
Juror Analyticals & Research Private Limited is audited by Mandovra and Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mandovra and Associates | FY 2023 | 03118C |
Shareholding
The shareholding of Juror Analyticals & Research Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Juror Analyticals & Research Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Juror Analyticals & Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Juror Analyticals & Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Juror Analyticals & Research Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Juror Analyticals & Research Private Limited has 2 board changes on record since 2016: 1 appointment and 1 cessation. The latest: Tapan Sharma ceased to be Director on 31 Jan 2026.
Frequently asked questions
Juror Analyticals & Research is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 17 May 2016 (10+ years old) and is registered under CIN U74999MP2016PTC040769.
Juror Analyticals & Research has 1 current director:
- Naman Sharma - Director
The latest financial statements of Juror Analyticals & Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Juror Analyticals & Research is U74999MP2016PTC040769. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Juror Analyticals & Research was incorporated on 17 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Juror Analyticals & Research by revenue are Malamed Life Science Private Limited, Ray Futuro Private Limited (OPC), Sphaera Pharma Research and Development Private Limited, Gomi'da Private Limited, Ishaan Research Labortories Private Limited and 5 more, all in the Pharma industry (Contract Research).
Tapan Sharma ceased to be Director on 31 Jan 2026. Naman Sharma was appointed as Director on 17 May 2016.
The registered office of Juror Analyticals & Research is at 142 Shanti Niketan Near Bombay Hospital, Indore, Madhya Pradesh, India – 452010.
Juror Analyticals & Research operates in the pharma industry, in the pharma contract r and d segment.
The compliance status of Juror Analyticals & Research is compliant as of 09 September 2026. The company is actively filing with the Registrar of Companies.
Juror Analyticals & Research can be reached at its registered office: 142 Shanti Niketan Near Bombay Hospital, Indore, Madhya Pradesh, India – 452010.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
